Skip to main content
Clinical Trials/ACTRN12607000613404
ACTRN12607000613404
Not yet recruiting
Phase 4

In patients with osteoarthritis of the knee does Ambrotose powder, Ambrotose AO, Phytomatrix and Plus 1, increase the quality of life and fatigue level?

Mannatech Australia Pty Ltd0 sites20 target enrollmentNovember 28, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Mannatech Australia Pty Ltd
Enrollment
20
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 28, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mannatech Australia Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • Females and males, aged between 18 and 85 years
  • X\-ray and clinical evidence of osteoarthritis of the knees
  • In good general health
  • Adequate venous access
  • Female participants of childbearing age who agree to continue using birth control measures for the duration of the study

Exclusion Criteria

  • A history of trauma associated with the affected joint
  • Rheumatoid or other inflammatory joint conditions
  • Individuals with thyroid disorder
  • Individuals with diabetes
  • Individuals taking antidepressants
  • Individuals taking Warfarin of other anti\-coagulant medication
  • Individuals who are lactose intolerant
  • Participants with a VAS score above 7 at baseline.
  • Participants who have just commenced on a treatment regimen for arthritis
  • Use of corticosteroids (intra\-articular or systematic) within 4 weeks prior to baseline and throughout the study

Outcomes

Primary Outcomes

Not specified

Similar Trials